Structure and Mechanism of the Bacterial Transporter Leut

Structure and Mechanism of the Bacterial Transporter Leut

STRUCTURE AND MECHANISM OF THE BACTERIAL TRANSPORTER LEUT By Chayne L. Piscitelli A DISSERTATION Presented to the Department of Biochemistry and Molecular Biology and the Oregon Health & Science University School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy January 2011 School of Medicine Oregon Health & Science University CERTIFICATE OF APPROVAL This is to certify that the Ph.D. dissertation of Chayne L. Piscitelli has been approved ______________________________________ Eric Gouaux, Mentor/Advisor ______________________________________ David Farrens, member ______________________________________ Buddy Ullman, member ______________________________________ Francis Valiyaveetil, member ______________________________________ Ujwal Shinde, member TABLE OF CONTENTS Acknowledgements ........................................................................................................ v List of Abbreviations ..................................................................................................... vi Abstract ............................................................................................................................ ix Chapter 1 Introduction and Fundamental Concepts .................................................................. 1 Crossing the membrane ............................................................................................. 2 Sodium-coupled secondary transport ....................................................................... 5 Neurotransmitter uptake by sodium-coupled secondary transporters ................... 7 Cloning of neurotransmitter transporters defines the NSS family .......................... 9 Disease and pharmacology of NSS family members ............................................... 11 Transport kinetics and thermodynamic coupling .................................................. 15 The crystal structure of LeuT .................................................................................. 20 Preview of this dissertation ..................................................................................... 24 Figures ......................................................................................................................... 28 Chapter 2 Substrate Specificity and Competitive Inhibition of LeuT .................................... 36 Abstract ....................................................................................................................... 37 Introduction ............................................................................................................... 38 Materials and Methods ............................................................................................. 40 Protein expression and purification for functional experiments ........................... 40 Preparation of LeuT proteoliposomes ..................................................................... 40 Inhibition of binding and transport screens ........................................................... 40 Saturation binding ................................................................................................... 41 i Competition binding ................................................................................................ 41 Steady-state kinetics ................................................................................................ 42 Tryptophan time course ........................................................................................... 42 Binding versus transport time course ..................................................................... 43 Inhibition kinetics .................................................................................................... 43 Preparation of LeuT-amino acid complex crystals ................................................. 43 Structure determination .......................................................................................... 45 Conformational shift analysis .................................................................................. 46 Results and Discussion ............................................................................................. 47 Substrate screen of LeuT .......................................................................................... 47 LeuT-substrate crystal structures reveal an occluded state .................................. 48 LeuT-Trp complex adopts an open-to-out conformation ....................................... 50 Second ligand binding site is unique to the open-to-out conformation ................. 52 A model for transport and inhibition ...................................................................... 53 Tables .......................................................................................................................... 57 Figures ......................................................................................................................... 60 Movie Legend ............................................................................................................. 73 Chapter 3 Stoichiometry of Substrate Binding to LeuT ........................................................... 74 Introduction ............................................................................................................... 75 Materials and Methods ............................................................................................. 76 Mutagenesis and protein purification ..................................................................... 76 Isothermal titration calorimetry ............................................................................. 77 Equilibrium dialysis ................................................................................................. 78 ii Scintillation proximity assays .................................................................................. 78 Transport time course.............................................................................................. 79 Steady-state kinetics ................................................................................................ 80 Results and Discussion ............................................................................................. 81 LeuT:substrate stoichiometry is 1:1 ......................................................................... 81 L400 mutants bind leucine equivalent to wildtype .................................................... 83 Clomipramine does not inhibit leucine binding ........................................................ 84 Transport activity is consistent with single-site kinetics .......................................... 85 Tables .......................................................................................................................... 88 Figures ......................................................................................................................... 96 Chapter 4 Engineering Tryptophan Transport Activity into LeuT ...................................... 102 Abstract ..................................................................................................................... 103 Introduction ............................................................................................................. 104 Materials and Methods ........................................................................................... 106 Homology modeling of TnaT ................................................................................. 106 Expression and purification ................................................................................... 107 Preparation of LeuT proteoliposomes ................................................................... 107 Transport assays .................................................................................................... 108 Binding assays ........................................................................................................ 108 Crystallization, data collection, model refinement ................................................. 109 Results and Discussion ........................................................................................... 110 LeuT-TnaT sequence alignment suggests altered binding site within a conserved structure ................................................................................. 110 iii TnaT homology model suggests binding site substiutions are specificity-altering ........................................................................................... 111 I359Q substitution in LeuT confers tryptophan transport activity to LeuT ........ 113 F259V does not inhibit binding of trp to LeuT ...................................................... 114 Steady-state kinetics of trp transport by LeuTI359Q............................................... 114 Trp transport active LeuT mutants bind trp in the occluded state...................... 114 The Trp602 site is absent in the Trp-bound occluded state ................................... 116 A structural description of the transport cycle ..................................................... 117 Tables ........................................................................................................................ 119 Figures ....................................................................................................................... 120 Chapter 5 Architectures and Archetypes of Sodium-Coupled

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    188 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us